Structure Therapeutics, Inc. (GPCR)
40.14
-0.70
(-1.71%)
USD |
NASDAQ |
May 07, 09:42
Structure Therapeutics Free Cash Flow : -226.41M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 10.37B |
| Viking Therapeutics, Inc. | -340.33M |
| Novo Nordisk A/S | 4.403B |
| Revolution Medicines, Inc. | -913.73M |
| Kymera Therapeutics, Inc. | -244.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -64.69M |
| Cash from Investing (Quarterly) | 56.31M |
| Cash from Financing (Quarterly) | 706.89M |
| Free Cash Flow Per Share (Quarterly) | -1.118 |
| Free Cash Flow to Equity (Quarterly) | -65.59M |
| Free Cash Flow to Firm (Quarterly) | -66.19M |
| Free Cash Flow Yield | -9.70% |